Cleaved Diagnostics
PrivateLast Round
Grant
Aug 13, 2025
Total Funding Raised
$355,000
Company Overview
Cleaved Diagnostics operates in Healthcare & Life Sciences and is based in New Orleans, Louisiana. Its latest recorded funding round was a Grant round in August 2025.
Cleaved Diagnostics is a biotechnology company that develops rapid, ultra-sensitive pathogen detection platforms using CRISPR-Cas12a technology for point-of-care diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cleaved Diagnostics Comparables
Compare Cleaved Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ginkgo Bioworks | 68% | |
| Danaher Corporation | 66% | |
| Mammoth Biosciences | 63% |
For institutional investors. Book with your work email.
Cleaved Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 13, 2025 | ||||
| Grant | Sep 1, 2024 |
For institutional investors. Book with your work email.
Cleaved Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tulane University Innovation Institute | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 13, 2025
$305K awarded by the National Science Foundation.
- Sep 1, 2024
$50K grant received from Tulane University Innovation Institute.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingNov 5, 2026
Cleaved receives $60K in prize money in 2026 after winning NOBIC’s BioChallenge, and uses the winnings to speed prototypes of CLEVR, a newborn hearing-loss screening tool.
- is_developingNov 3, 2026
Cleaved is developing CLEVR, a rapid CRISPR-based test designed to detect cytomegalovirus, the leading non-genetic cause of hearing loss in children, using research from Tulane University in Louisiana.
- attends_eventNov 3, 2026
Cleaved wins first place and the crowd favorite award at the 2026 BioChallenge pitch competition held in Louisiana on Oct 29th '26.
- receives_awardNov 3, 2026
The New Orleans BioInnovation Center announces that Cleaved wins first place and the crowd favorite award at the 2026 BioChallenge pitch competition in Louisiana on Oct 29th '26.
For institutional investors. Book with your work email.
Cleaved Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cleaved Diagnostics's valuation, stock price, and market status.
Is Cleaved Diagnostics a public or private company?
Cleaved Diagnostics is a private company.
What is the current stock price of Cleaved Diagnostics?
Cleaved Diagnostics is a private company, so its shares have no public market price. Caplight tracks Cleaved Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cleaved Diagnostics worth (valuation)?
Valuation information for Cleaved Diagnostics is not publicly available.
Can I buy Cleaved Diagnostics stock?
Cleaved Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cleaved Diagnostics's last funding round?
Cleaved Diagnostics's most recent funding round was Grant on August 13, 2025.
Who are the main investors in Cleaved Diagnostics?
Key investors in Cleaved Diagnostics include Tulane University Innovation Institute, National Science Foundation.
Will Cleaved Diagnostics IPO soon?
No public IPO plans have been announced for Cleaved Diagnostics.
How can I track Cleaved Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Cleaved Diagnostics's shares on secondary markets.